Reply to Comment on : Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines
| Errataetall: |
CommentOn: Am J Ophthalmol. 2020 Nov;219:101-106. - PMID 32610049 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:222 |
|---|---|
| Enthalten in: |
American journal of ophthalmology - 222(2021) vom: 22. Feb., Seite 400-401 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Browning, David J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4QWG6N8QKH |
|---|
| Anmerkungen: |
Date Completed 11.03.2021 Date Revised 11.03.2021 published: Print-Electronic CommentOn: Am J Ophthalmol. 2020 Nov;219:101-106. - PMID 32610049 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ajo.2020.09.015 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317958968 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317958968 | ||
| 003 | DE-627 | ||
| 005 | 20231225164343.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajo.2020.09.015 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1059.xml |
| 035 | |a (DE-627)NLM317958968 | ||
| 035 | |a (NLM)33228963 | ||
| 035 | |a (PII)S0002-9394(20)30509-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Browning, David J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reply to Comment on |b Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2021 | ||
| 500 | |a Date Revised 11.03.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Am J Ophthalmol. 2020 Nov;219:101-106. - PMID 32610049 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 700 | 1 | |a Yokogawa, Naoto |e verfasserin |4 aut | |
| 700 | 1 | |a Greenberg, Paul B |e verfasserin |4 aut | |
| 700 | 1 | |a Perlman, Elliot |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of ophthalmology |d 1945 |g 222(2021) vom: 22. Feb., Seite 400-401 |w (DE-627)NLM000124443 |x 1879-1891 |7 nnns |
| 773 | 1 | 8 | |g volume:222 |g year:2021 |g day:22 |g month:02 |g pages:400-401 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajo.2020.09.015 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 222 |j 2021 |b 22 |c 02 |h 400-401 | ||